Safety and efficacy of Motilitone (DA-9701) in migraine patients with gastrointestinal symptoms
Latest Information Update: 30 Jul 2018
At a glance
- Drugs DA 9701 (Primary)
- Indications Gastrointestinal disorders; Nausea and vomiting
- Focus Adverse reactions; Therapeutic Use
- 30 Jul 2018 New trial record
- 01 Jul 2018 Results presented at the 60th Annual Scientific Meeting of the American Headache Society